Antidepressant use during pregnancy and the risk for gestational diabetes: a systematic review and meta-analysis

References

• Williams T, Stein DJ, Ipser J. A systematic review of network meta-analyses for pharmacological treatment of common mental disorders. Evid Based Ment Health. 2018;21(1):7–11.
   PubMed Web of Science ®Google Scholar
• Mercier A, Auger-Aubin I, Lebeau JP, et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Fam Pract. 2013;14:55.
   PubMed Web of Science ®Google Scholar
• Bogowicz P, Curtis HJ, Walker AJ, et al. Trends and variation in antidepressant prescribing in English primary care: a retrospective longitudinal study. BJGP Open. 2021;5(4):BJGPO.2021.0020.
   PubMedGoogle Scholar
• Masarwa R, Lefebvre C, Platt RW, et al. General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998–2018. Pharmacoepidemiol Drug Saf. 2022;31(3):302–313.
   PubMed Web of Science ®Google Scholar
• Molenaar NM, Bais B, Lambregtse-van den Berg MP, et al. The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability. J Affect Disord. 2020;264:82–89.
   PubMed Web of Science ®Google Scholar
• Saravanan P. Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol. 2020;8(9):793–800.
   PubMed Web of Science ®Google Scholar
• Bastidas K, Romero XC, Uriel M, et al. Perinatal outcomes associated with the diagnosis of gestational diabetes: systematic review and meta-analysis. Diabetes Metab Syndr. 2021;15(5):102262.
   PubMed Web of Science ®Google Scholar
• Bidhendi Yarandi R, Vaismoradi M, Panahi MH, et al. Mild gestational diabetes and adverse pregnancy outcome: a systemic review and meta-analysis. Front Med. 2021;8:699412.
   Web of Science ®Google Scholar
• Liu B, Ruz-Maldonado I, Toczyska K, et al. The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta-cell mass. Diabetes Obes Metab. 2022;24(10):2038–2050.
   PubMed Web of Science ®Google Scholar
• Isaac R, Boura-Halfon S, Gurevitch D, et al. Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells. J Biol Chem. 2013;288(8):5682–5693.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S, Bhattacharya R, Kelley GA, et al. Antidepressant use and new-onset diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2013;29(4):273–284.
   PubMed Web of Science ®Google Scholar
• Gill H, Gill B, El-Halabi S, et al. Antidepressant medications and weight change: a narrative review. Obesity. 2020;28(11):2064–2072.
   PubMed Web of Science ®Google Scholar
• Wen SW, Yang Q, Garner P, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006;194(4):961–966.
   PubMed Web of Science ®Google Scholar
• Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40(10):1723–1733.
   PubMed Web of Science ®Google Scholar
• Dandjinou M, Sheehy O, Berard A. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study. BMJ Open. 2019;9(9):e025908.
   PubMed Web of Science ®Google Scholar
• Wartko PD, Weiss NS, Enquobahrie DA, et al. Antidepressant continuation in pregnancy and risk of gestational diabetes. Pharmacoepidemiol Drug Saf. 2019;28(9):1194–1203.
   PubMed Web of Science ®Google Scholar
• Lupattelli A, Barone-Adesi F, Nordeng H. Association between antidepressant use in pregnancy and gestational diabetes mellitus: results from the Norwegian mother, father and child cohort study. Pharmacoepidemiol Drug Saf. 2022;31(2):247–256.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
   PubMed Web of Science ®Google Scholar
• Higgins JP. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration; 2014 [cited 2014 Dec 6]. Available from: www.cochrane-handbook.org
   Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Hennings JM, Schaaf L, Fulda S. Glucose metabolism and antidepressant medication. Curr Pharm Des. 2012;18(36):5900–5919.
   PubMed Web of Science ®Google Scholar
• Levkovitz Y, Ben-Shushan G, Hershkovitz A, et al. Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases. Mol Cell Neurosci. 2007;36(3):305–312.
   PubMed Web of Science ®Google Scholar
• Carvalho F, Barros D, Silva J, et al. Hyperglycemia induced by acute central fluoxetine administration: role of the Central CRH system and 5-HT3 receptors. Neuropeptides. 2004;38(2-3):98–105.
   PubMed Web of Science ®Google Scholar
• Horackova H, Karahoda R, Cerveny L, et al. Effect of selected antidepressants on placental homeostasis of serotonin: maternal and fetal perspectives. Pharmaceutics. 2021;13(8):1306.
   PubMed Web of Science ®Google Scholar
• Baeyens L, Hindi S, Sorenson RL, et al. β-Cell adaptation in pregnancy. Diabetes Obes Metab. 2016;18 Suppl 1(Suppl 1):63–70.
   PubMedGoogle Scholar
• Salvi V, Mencacci C, Barone-Adesi F. H1-histamine receptor affinity predicts weight gain with antidepressants. Eur Neuropsychopharmacol. 2016;26(10):1673–1677.
   PubMed Web of Science ®Google Scholar
• Qiu W, Cai X, Zheng C, et al. Update on the relationship between depression and neuroendocrine metabolism. Front Neurosci. 2021;15:728810.
   PubMed Web of Science ®Google Scholar
• Khoza S, Barner JC. Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports. Int J Clin Pharm. 2011;33(3):484–492.
   PubMed Web of Science ®Google Scholar
• Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry. 2013;74(1):31–37.
   PubMed Web of Science ®Google Scholar
• Harvey BH, Bouwer CD. Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors. Clin Neuropharmacol. 2000;23(2):90–97.
   PubMed Web of Science ®Google Scholar
• Coutens B, Yrondi A, Rampon C, et al. Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine. Psychopharmacology. 2022;239(9):2735–2752.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu D, Li X, et al. Antidepressants use and the risk of type 2 diabetes mellitus: a systematic review and meta-analysis. J Affect Disord. 2021;287:41–53.
   PubMed Web of Science ®Google Scholar